Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03385226 |
Title | A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) (PORT) |
Acronym | PORT |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | University College, London |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | GBR |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University Hospital Birmingham | Birmingham | United Kingdom | Details | |||
Velindre Cancer Centre | Cardiff | United Kingdom | Details | |||
University Hospital Coventry | Coventry | United Kingdom | Details | |||
Beatson West of Scotland Cancer Centre | Glasgow | United Kingdom | Details | |||
Guy's & St Thomas' | London | United Kingdom | Details | |||
The Christie | Manchester | United Kingdom | Details | |||
Freeman Hospital | Newcastle | United Kingdom | Details | |||
Nottingham City Hospital | Nottingham | United Kingdom | Details | |||
Churchill Hospital | Oxford | United Kingdom | Details | |||
Southampton University Hospital | Southampton | United Kingdom | Details | |||
Clatterbridge Cancer Centre | Wirral | United Kingdom | Details |